2022

Schold JD, Nordyke RJ, Wu Z, Corvino F, Wang W, Mohan S. 2022. Clinical events and renal function in the first year predict long-term kidney transplant survival. Kidney360 3(4):714-727; doi: 10.34067/KID.0007342021. PMID: 35721618.

View Abstract

Röth A, Fryzek J, Jiang X, Reichert H, Patel P, Su J, Morales Arias J, Broome CM. 2022. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion 62(1):51-59; doi: 10.1111/trf.16745. PMID: 34813663.

View Abstract

2021

Mavunda K, Jiang X, Ambrose CS. 2021. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age. J Neonatal Perinatal Med 14(1):43–51; doi: 10.3233/NPM-200412. PMID: 32474477.

View Abstract

Hooda N, Svane HML, Fryzek J, Nicoholson G, White JB, Edris B, Smith LM, Petersen MM, et al. The epidemiology of desmoid tumors in Denmark. Poster presented at the Connective Tissue Oncology Society Annual Meeting, November 2021.

Rana ZH, Frankenfeld CL, de Jonge L, Kennedy EJ, Bertoldo J, Short JL, Cheskin LJ. 2021. Dietary intake and representativeness of a diverse college-attending population compared with an age-matched US population. Nutrients 13:3810; doi: 10.3390/nu13113810. PMID: 34836066.

View Abstract

Feuerstadt P, Boules M, Stong L, Dahdal DN, Sacks NC, Lang K, Nelson WW. 2021. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis. SAGE Open Med 9:2050312120986733; doi: 10.1177/2050312120986733. PMID: 33505698.

View Abstract

Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer 125(10):1432-1442; doi: 10.1038/s41416-021-01498-4. PMID: 34426664.

View Abstract

Nielson CM, Bylsma LC, Fryzek JP, Saad HA, Crawford J. 2021. Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: A systematic review and meta-analysis. Oncologist 26(9):e1609–e1618; doi: 10.1002/onco.13822. PMID: 33973301.

View Abstract

Snell Taylor SJ, Nielson CM, Breskin A, Saul B, Yu Y, Alam N, … Kelsh M, et al. 2021. Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic immune thrombocytopenia in European clinical practice. Adv Ther 38(5):2673–2688; doi: 10.1007/s12325-021-01727-5. PMID: 33866516.

View Abstract

McGrath LJ, Nielson C, Saul B, Breskin A, Yu Y, Nicolaisen SK, … Kelsh M, et al. 2021. Lessons learned using real-world data to emulate randomized trials: A case study of treatment effectiveness for newly diagnosed immune thrombocytopenia. Clin Pharmacol Ther 110(6):1570–1578; doi: 10.1002/cpt.2399. PMID: 34416023.

View Abstract